You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Psoriasis

Adalimumab for the treatment of adults with psoriasis

  • Technology appraisal guidance
  • Reference number: TA146
  • Published:  25 June 2008
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Appraisal Committee members and NICE project team
  • 8 Sources of evidence considered by the Committee

6 Recommendations for further research

6.1

The Committee recommends that further research should be conducted comparing available anti-tumour necrosis factor (TNF) agents (such as adalimumab, etanercept and infliximab) with each other.


Next page 7 Appraisal Committee members and NICE project team Previous page 5 Implementation
Back to top